Abstract
Of eight young women, seven had a diagnosis of well-differentiated endometrial adenocarcinoma and one had atypical endometrial hyperplasia. The average age was 40.1 years, with 6.04 years of dimethisterone-ethinyl estradiol (Oracon) sequential contraceptive use. The patients were not typical of those in whom endometrial carcinoma develops. Although these cases do not prove that long-term administration of dimethisterone-ethinyl estradiol causes endometrial adenocarcinoma or atypia, they indicate that it may do so.
Original language | English (US) |
---|---|
Pages (from-to) | 923-926 |
Number of pages | 4 |
Journal | Journal of the American Medical Association |
Volume | 236 |
Issue number | 8 |
DOIs | |
State | Published - Aug 23 1976 |
ASJC Scopus subject areas
- General Medicine